Tissue-specific expression of a suicide gene for selective killing of neuroblastoma cells using a promoter region of the NCX gene
- PMID: 11781663
- DOI: 10.1038/sj.cgt.7700408
Tissue-specific expression of a suicide gene for selective killing of neuroblastoma cells using a promoter region of the NCX gene
Abstract
The human NCX gene, a homologue of the murine neural crest homeobox (Ncx/Hox11L.1) gene whose expression is restricted to a subset of neural crest-derived tissues, was expressed in human neuroblastoma cells but not in other tumors or fibroblasts. A 4.5-kb genomic fragment in the 5'-flanking region of the NCX gene efficiently transcribed the fused luciferase reporter gene in human neuroblastoma cells but not in non-neuroblastoma cells. Sequential deletion of this regulatory region from the 5' side demonstrated that a 1.7-kb fragment upstream from the start codon retained the preferential promoter activity in neuroblastoma cells. The transcriptional activation by the NCX promoter was stronger than that by the SV40 T antigen promoter in human neuroblastoma cells. Transfection of neuroblastoma cells with the NCX promoter-linked herpes simplex virus-thymidine kinase (HSV-TK) gene increased their sensitivity to ganciclovir. The regulatory region of the NCX gene is thus useful for neuroblastoma-specific suicide gene therapy.
Comment in
-
Neuroblastoma-specific expression of potential therapeutics cannot be achieved using a promoter region of the NCX (TLX2) gene.Cancer Gene Ther. 2010 May;17(5):373-4. doi: 10.1038/cgt.2009.90. Epub 2010 Jan 22. Cancer Gene Ther. 2010. PMID: 20094074 Free PMC article. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
